Longbow Finance’s AbbVie ABBV Stock Holding History

Longbow Finance’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.24M	Sell	24,793 -21,125	-46%	-$4.54M	0.8%	49
2026 Q1	$9.99M	Sell	45,918 -15,209	-25%	-$3.37M	1.81%	14
2025 Q4	$14M	Sell	61,127 -37,716	-38%	-$8.59M	2.36%	9
2025 Q3	$22.9M	Hold	98,843	–	–	2.26%	10
2025 Q2	$18.3M	Buy	98,843 +37,626	+61%	+$6.99M	1.96%	12
2025 Q1	$12.8M	Buy	61,217 +21,952	+56%	+$4.27M	1.54%	17
2024 Q4	$6.98M	Buy	39,265 +1,860	+5%	+$342K	0.76%	44
2024 Q3	$7.39M	Buy	37,405 +8,641	+30%	+$1.61M	0.79%	33
2024 Q2	$4.93M	Sell	28,764 -1,544	-5%	-$256K	0.51%	46
2024 Q1	$5.52M	Buy	+30,308	New	+$5.22M	0.56%	48

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Longbow Finance's ABBV Position: Q2 2026 in Review

Longbow Finance reduced its AbbVie (ABBV) stake by 46% in Q2 2026, selling an estimated $4.54M and leaving 24,793 shares worth $6.24M. The position accounts for 0.8% of the portfolio, ranked #49.

Longbow Finance first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $22.9M in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Longbow Finance held 24,793 shares of AbbVie worth $6.24M as of Q2 2026.
Longbow Finance sold 21,125 AbbVie shares in Q2 2026, an estimated $4.54M.
AbbVie made up 0.8% of Longbow Finance's portfolio in Q2 2026, its #49 holding.
Longbow Finance first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Longbow Finance's AbbVie position peaked at $22.9M in Q3 2025.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Longbow Finance's 13F filing for Q2 2026, filed 29 Jul 2026.